Shenzhen Glory Medical Co.,Ltd. Logo

Shenzhen Glory Medical Co.,Ltd.

002551.SZ

(1.0)
Stock Price

3,25 CNY

-4.04% ROA

-5.51% ROE

-19.08x PER

Market Cap.

2.792.950.527,00 CNY

13.65% DER

0% Yield

-12.06% NPM

Shenzhen Glory Medical Co.,Ltd. Stock Analysis

Shenzhen Glory Medical Co.,Ltd. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Shenzhen Glory Medical Co.,Ltd. Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a low debt to equity ratio (11%), which means it has a small amount of debt compared to the ownership it holds

2 PBV

The stock's PBV ratio (1.34x) indicates a justifiable valuation, presenting a compelling choice for investors seeking reasonable returns.

3 Graham Number

The Graham number analysis indicates that this company's stock price is likely undervalued, raising prospects for a favorable investment opportunity.

4 ROE

The stock's ROE indicates a negative return (-9.79%) on shareholders' equity, suggesting poor financial performance.

5 ROA

The stock's ROA (-6.99%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

6 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

7 Net Profit Growth

This company's net profit has remained flat over the past five years, suggesting a lack of growth and making it a less attractive investment opportunity.

8 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

9 Dividend Growth

The company's dividend growth has remained unchanged for three years, signaling a lack of positive momentum and making it a less favorable investment choice.

10 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

11 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is overpriced (-11), presenting a possible disadvantage for investors as its market price surpasses its estimated intrinsic value.

Shenzhen Glory Medical Co.,Ltd. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Shenzhen Glory Medical Co.,Ltd. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Sell
2 MACD Buy
3 RSI Hold
4 Stoch RSI Hold

Shenzhen Glory Medical Co.,Ltd. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Shenzhen Glory Medical Co.,Ltd. Revenue
Year Revenue Growth
2007 116.371.490
2008 138.067.817 15.71%
2009 208.510.549 33.78%
2010 270.035.501 22.78%
2011 348.427.757 22.5%
2012 421.318.874 17.3%
2013 730.900.907 42.36%
2014 1.166.777.462 37.36%
2015 1.666.319.455 29.98%
2016 1.946.049.938 14.37%
2017 2.006.477.112 3.01%
2018 1.630.432.068 -23.06%
2019 1.530.819.966 -6.51%
2020 2.267.293.874 32.48%
2021 1.790.296.234 -26.64%
2022 1.275.709.968 -40.34%
2023 1.275.289.146 -0.03%
2023 1.192.887.048 -6.91%
2024 1.399.502.288 14.76%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Shenzhen Glory Medical Co.,Ltd. Research and Development Expenses
Year Research and Development Expenses Growth
2007 4.105.329
2008 3.624.357 -13.27%
2009 5.347.381 32.22%
2010 5.823.961 8.18%
2011 7.740.342 24.76%
2012 11.326.641 31.66%
2013 20.773.154 45.47%
2014 31.039.190 33.07%
2015 41.493.159 25.19%
2016 45.996.386 9.79%
2017 50.715.908 9.31%
2018 46.235.735 -9.69%
2019 47.889.131 3.45%
2020 61.168.443 21.71%
2021 52.367.943 -16.81%
2022 48.182.370 -8.69%
2023 46.169.511 -4.36%
2023 40.074.275 -15.21%
2024 45.304.424 11.54%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Shenzhen Glory Medical Co.,Ltd. General and Administrative Expenses
Year General and Administrative Expenses Growth
2007 3.951.362
2008 7.619.503 48.14%
2009 11.695.633 34.85%
2010 8.011.608 -45.98%
2011 12.751.890 37.17%
2012 14.478.628 11.93%
2013 17.409.162 16.83%
2014 22.741.667 23.45%
2015 43.650.496 47.9%
2016 33.246.874 -31.29%
2017 41.586.568 20.05%
2018 24.179.097 -71.99%
2019 31.746.072 23.84%
2020 39.296.144 19.21%
2021 43.065.880 8.75%
2022 40.174.914 -7.2%
2023 404.878.890 90.08%
2023 40.718.980 -894.32%
2024 -108.169.856 137.64%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Shenzhen Glory Medical Co.,Ltd. EBITDA
Year EBITDA Growth
2007 28.997.956
2008 35.589.628 18.52%
2009 51.620.681 31.06%
2010 70.797.264 27.09%
2011 68.755.248 -2.97%
2012 102.316.922 32.8%
2013 138.275.044 26%
2014 198.178.426 30.23%
2015 245.513.538 19.28%
2016 272.391.129 9.87%
2017 279.570.683 2.57%
2018 271.720.182 -2.89%
2019 180.623.935 -50.43%
2020 438.187.168 58.78%
2021 203.403.502 -115.43%
2022 125.791.005 -61.7%
2023 20.939.682 -500.73%
2023 89.771.087 76.67%
2024 189.651.440 52.67%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Shenzhen Glory Medical Co.,Ltd. Gross Profit
Year Gross Profit Growth
2007 45.647.618
2008 58.534.260 22.02%
2009 86.243.310 32.13%
2010 107.302.583 19.63%
2011 105.289.343 -1.91%
2012 160.557.732 34.42%
2013 222.531.846 27.85%
2014 330.272.080 32.62%
2015 436.738.271 24.38%
2016 474.990.706 8.05%
2017 472.745.246 -0.47%
2018 401.976.143 -17.61%
2019 329.820.273 -21.88%
2020 694.709.183 52.52%
2021 362.939.368 -91.41%
2022 221.877.232 -63.58%
2023 225.053.830 1.41%
2023 197.604.253 -13.89%
2024 119.121.908 -65.88%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Shenzhen Glory Medical Co.,Ltd. Net Profit
Year Net Profit Growth
2007 22.011.923
2008 24.118.784 8.74%
2009 39.878.888 39.52%
2010 46.393.062 14.04%
2011 44.157.770 -5.06%
2012 58.331.527 24.3%
2013 73.755.530 20.91%
2014 102.156.755 27.8%
2015 119.056.313 14.19%
2016 114.153.558 -4.29%
2017 175.160.241 34.83%
2018 97.710.771 -79.26%
2019 59.758.852 -63.51%
2020 369.948.965 83.85%
2021 88.019.613 -320.3%
2022 -327.902.476 126.84%
2023 7.848.104 4278.11%
2023 -148.889.156 105.27%
2024 572.636 26100.66%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Shenzhen Glory Medical Co.,Ltd. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2007 0
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Shenzhen Glory Medical Co.,Ltd. Free Cashflow
Year Free Cashflow Growth
2007 -14.498.691
2008 -42.945.564 66.24%
2009 -24.347.059 -76.39%
2010 35.580.896 168.43%
2011 -65.061.211 154.69%
2012 18.977.022 442.84%
2013 -169.201.485 111.22%
2014 -91.090.563 -85.75%
2015 133.793.844 168.08%
2016 139.590.529 4.15%
2017 -109.648.087 227.31%
2018 -315.058.155 65.2%
2019 -114.733.726 -174.6%
2020 243.328.466 147.15%
2021 -187.375.935 229.86%
2022 39.151.278 578.59%
2023 55.368.007 29.29%
2023 -24.440.541 326.54%
2024 28.272.296 186.45%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Shenzhen Glory Medical Co.,Ltd. Operating Cashflow
Year Operating Cashflow Growth
2007 25.568.448
2008 -3.678.935 795%
2009 58.140.122 106.33%
2010 50.984.723 -14.03%
2011 -56.528.183 190.19%
2012 31.734.303 278.13%
2013 -84.572.546 137.52%
2014 -14.052.014 -501.85%
2015 217.624.979 106.46%
2016 281.418.286 22.67%
2017 235.393.625 -19.55%
2018 42.215.864 -457.6%
2019 139.878.758 69.82%
2020 497.535.712 71.89%
2021 242.597.270 -105.09%
2022 96.453.250 -151.52%
2023 60.462.955 -59.52%
2023 17.633.369 -242.89%
2024 34.617.285 49.06%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Shenzhen Glory Medical Co.,Ltd. Capital Expenditure
Year Capital Expenditure Growth
2007 40.067.139
2008 39.266.630 -2.04%
2009 82.487.181 52.4%
2010 15.403.826 -435.5%
2011 8.533.028 -80.52%
2012 12.757.280 33.11%
2013 84.628.939 84.93%
2014 77.038.549 -9.85%
2015 83.831.134 8.1%
2016 141.827.756 40.89%
2017 345.041.712 58.9%
2018 357.274.019 3.42%
2019 254.612.484 -40.32%
2020 254.207.245 -0.16%
2021 429.973.205 40.88%
2022 57.301.971 -650.36%
2023 5.094.948 -1024.68%
2023 42.073.910 87.89%
2024 6.344.989 -563.1%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Shenzhen Glory Medical Co.,Ltd. Equity
Year Equity Growth
2007 83.046.161
2008 172.189.473 51.77%
2009 229.219.425 24.88%
2010 275.995.643 16.95%
2011 1.180.601.026 76.62%
2012 1.219.644.562 3.2%
2013 1.334.944.230 8.64%
2014 1.456.842.055 8.37%
2015 1.581.430.487 7.88%
2016 2.170.920.886 27.15%
2017 2.673.203.666 18.79%
2018 2.777.612.563 3.76%
2019 2.816.091.465 1.37%
2020 3.645.402.644 22.75%
2021 3.446.356.900 -5.78%
2022 2.999.284.584 -14.91%
2023 2.939.606.503 -2.03%
2023 2.747.755.814 -6.98%
2024 2.765.327.027 0.64%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Shenzhen Glory Medical Co.,Ltd. Assets
Year Assets Growth
2007 210.696.659
2008 318.097.401 33.76%
2009 403.049.185 21.08%
2010 488.620.580 17.51%
2011 1.328.395.755 63.22%
2012 1.523.422.541 12.8%
2013 2.019.169.226 24.55%
2014 2.356.465.595 14.31%
2015 2.958.341.194 20.35%
2016 4.058.185.024 27.1%
2017 4.310.397.456 5.85%
2018 4.104.575.599 -5.01%
2019 4.720.016.329 13.04%
2020 5.061.310.162 6.74%
2021 4.973.151.763 -1.77%
2022 4.260.470.294 -16.73%
2023 4.177.485.526 -1.99%
2023 3.931.719.261 -6.25%
2024 3.902.165.496 -0.76%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Shenzhen Glory Medical Co.,Ltd. Liabilities
Year Liabilities Growth
2007 127.650.498
2008 145.907.927 12.51%
2009 173.829.759 16.06%
2010 212.624.936 18.25%
2011 147.794.727 -43.87%
2012 303.777.978 51.35%
2013 684.224.995 55.6%
2014 899.623.539 23.94%
2015 1.376.910.706 34.66%
2016 1.887.264.138 27.04%
2017 1.637.193.789 -15.27%
2018 1.326.963.035 -23.38%
2019 1.903.924.863 30.3%
2020 1.415.907.517 -34.47%
2021 1.526.794.863 7.26%
2022 1.261.185.708 -21.06%
2023 1.237.879.023 -1.88%
2023 1.183.963.445 -4.55%
2024 1.055.017.672 -12.22%

Shenzhen Glory Medical Co.,Ltd. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
1.44
Net Income per Share
-0.17
Price to Earning Ratio
-19.08x
Price To Sales Ratio
2.3x
POCF Ratio
45.5
PFCF Ratio
126.18
Price to Book Ratio
1.06
EV to Sales
2.18
EV Over EBITDA
57.24
EV to Operating CashFlow
43.1
EV to FreeCashFlow
119.53
Earnings Yield
-0.05
FreeCashFlow Yield
0.01
Market Cap
2,79 Bil.
Enterprise Value
2,65 Bil.
Graham Number
3.49
Graham NetNet
0.5

Income Statement Metrics

Net Income per Share
-0.17
Income Quality
-0.42
ROE
-0.06
Return On Assets
-0.04
Return On Capital Employed
-0.04
Net Income per EBT
1.26
EBT Per Ebit
0.93
Ebit per Revenue
-0.1
Effective Tax Rate
-0.33

Margins

Sales, General, & Administrative to Revenue
0.03
Research & Developement to Revenue
0.03
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.13
Operating Profit Margin
-0.1
Pretax Profit Margin
-0.1
Net Profit Margin
-0.12

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
-0.4
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0.07
Free CashFlow per Share
0.03
Capex to Operating CashFlow
0.64
Capex to Revenue
0.03
Capex to Depreciation
0.3
Return on Invested Capital
-0.06
Return on Tangible Assets
-0.04
Days Sales Outstanding
181.92
Days Payables Outstanding
95.02
Days of Inventory on Hand
120.61
Receivables Turnover
2.01
Payables Turnover
3.84
Inventory Turnover
3.03
Capex per Share
0.05

Balance Sheet

Cash per Share
1,00
Book Value per Share
3,37
Tangible Book Value per Share
3.05
Shareholders Equity per Share
3.11
Interest Debt per Share
0.43
Debt to Equity
0.14
Debt to Assets
0.09
Net Debt to EBITDA
-3.18
Current Ratio
1.84
Tangible Asset Value
2,57 Bil.
Net Current Asset Value
0,77 Bil.
Invested Capital
1598737739
Working Capital
0,83 Bil.
Intangibles to Total Assets
0.07
Average Receivables
0,58 Bil.
Average Payables
0,27 Bil.
Average Inventory
357040480.5
Debt to Market Cap
0.13

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Shenzhen Glory Medical Co.,Ltd. Dividends
Year Dividends Growth
2011 0
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2017 0 0%
2018 0 0%
2019 0 0%

Shenzhen Glory Medical Co.,Ltd. Profile

About Shenzhen Glory Medical Co.,Ltd.

Shenzhen Glory Medical Co., Ltd. provides hospital construction and medical system integrated solutions in China. The company is involved in the planning, design, management, and implementation of hospital construction projects; installation of medical professional engineering; and medical software development activities. It also sells medical protective equipment, which includes non-woven surgical gowns and medical surgical kits; and medical disposal protective clothing, isolation gowns, and mask, as well as medical surgical consumables. In addition, the company offers medical information solutions, comprising digital operating rooms, surgical teaching systems, remote surgical consultation, mobile digital video station, central management platforms, and digital pre-hospital emergency platforms. Further it provides professional housing and system management, medical equipment maintenance, medical guidance, carer/accompaniment, logistics management, cleaning and greening, security guard, food, and parking lot management services. Shenzhen Glory Medical Co., Ltd. was founded in 1998 and is based in Shenzhen, China.

CEO
Mr. Guiqiu Liang
Employee
1.345
Address
Shangrong Technology Industrial Park
Shenzhen, 518116

Shenzhen Glory Medical Co.,Ltd. Executives & BODs

Shenzhen Glory Medical Co.,Ltd. Executives & BODs
# Name Age
1 Mr. Yong You
Chief Financial Officer & Head of Accounting Agency
70
2 Mr. Jierui Zhang
Deputy GM & Director
70
3 Ms. Li Song
Deputy General Manager
70
4 Mr. Guitian Liang
Vice Chairman of the Board & Deputy GM
70
5 Mr. Guiqiu Liang
Chairman & GM
70
6 Mr. Wen Bin Zhang
Deputy General Manager
70
7 Ms. Li Lin
Deputy GM & Board Secretary
70

Shenzhen Glory Medical Co.,Ltd. Competitors